Human JAR Placental Villus Cancer Cells (JAR)

  • Human JAR Placental Villus Cancer Cells (JAR) Packages (Simulation)
  • Human JAR Placental Villus Cancer Cells (JAR) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Biosafety of the Human JAR Placental Villus Cancer Cells (JAR)

Human JAR Placental Villus Cancer Cells (JAR) are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi.

Cluture Conditions of the Human JAR Placental Villus Cancer Cells (JAR)

Complete growth medium:DMEM+10% FBS+1% Penicillin-Streptomycin Solution. Temperature: 37℃. Condition: 95% air, 5% carbon dioxide

Product Format of the Human JAR Placental Villus Cancer Cells (JAR)

Frozen 1 mL or T25 flask.

USAGE of the Human JAR Placental Villus Cancer Cells (JAR)

Upon receiving the cells in a T-25 flask at room temperature, immediately transfer the cells to 37°C, 5% incubator; the cells in vials, directly and immediately transfer the cells from dry ice to liquid nitrogen.

GIVEAWAYS

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
UCSI335Hu11 Human JAR Placental Villus Cancer Cells (JAR) For research use only. It is not approved for human or animal use, or for applications in in vitro diganostic procedures.
UMSI335Hu11 Medium for Human JAR Placental Villus Cancer Cells (JAR) Complete Medium for the culture of JAR cell line
GUESTBOOK